Literature DB >> 26413980

Small-to-moderate decreases in cold hypersensitivity up to 3 years after severe hand injuries: A prospective cohort study.

T Vaksvik1,2, M Røkkum3, J R Haugstvedt4, I Holm2,5.   

Abstract

BACKGROUND: The natural course and predictors for decreased cold hypersensitivity were studied in 85 patients with severe hand injuries involving nerve lesions.
METHODS: Questionnaires including the McCabe Cold Sensitivity Severity scale (CSS 0-400) were collected after injury, and at 6-month, 12-month, 2-year, and 3-year follow-ups.
RESULTS: Between the 12-month and 3-year follow-up, there was a small decrease in cold hypersensitivity as measured by the CSS (median = 24; Q1-Q3 = -11-75; n = 85). Five of the patients recovered from cold hypersensitivity, and ∼ 40% of the patients were less affected by cold hypersensitivity in daily life. Little or no pain early after injury and higher CSS-scores 12 months after primary surgery were weakly associated with the reduced CSS-scores (R(2) = 0.20) at the 3-year follow-up. Six patients had changed work or did not work due to cold hypersensitivity, but the majority of the patients had kept their cold-exposed work.
CONCLUSION: Cold-hypersensitive patients may have a reasonable chance for decreased cold sensitivity and cold-associated activity limitations over time, although the majority of the patients will experience persistent problems. Tools to predict improvement remain insufficient.

Entities:  

Keywords:  McCabe Cold Sensitivity Severity scale CSS; activities of daily living; cold hypersensitivity; cold intolerance; cold sensitivity; hand injury; nerve injury

Mesh:

Year:  2015        PMID: 26413980     DOI: 10.3109/2000656X.2015.1089877

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  1 in total

1.  Patient satisfaction after innervated digital artery perforator flap for fingertip injuries.

Authors:  Egemen Ayhan; Kadir Çevik; Velat Çelik; Metin Manouchehr Eskandari
Journal:  Acta Orthop Traumatol Turc       Date:  2020-05       Impact factor: 1.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.